The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep
- 7 July 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 217 (2-3) , 119-126
- https://doi.org/10.1016/0014-2999(92)90829-s
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry AirNew England Journal of Medicine, 1990
- Urinary leukotriene E4 levels during early and late asthmatic responses†Journal of Allergy and Clinical Immunology, 1990
- Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of asthmaScience, 1990
- Leukotrienes and inflammationPharmacology & Therapeutics, 1990
- URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITISThe Lancet, 1989
- The Role of Leukotrienes in Allergen‐induced Late Responses in Allergic SheepaAnnals of the New York Academy of Sciences, 1988
- Leukotrienes in inflammationInflammation Research, 1986
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980